StrideBio, Inc, based in Durham, NC, is at the forefront of the gene therapy revolution, dedicated to developing cutting-edge gene therapies for individuals facing life-threatening diseases. With a strong commitment to superior drug development, high industry standards, and an innovative team that translates scientific advancements into life-saving treatments, StrideBio aims to be the leader in the evolution of gene therapy.
Driven by a mission to prolong and improve lives, StrideBio envisions a future where their best-in-class gene therapies become the gold standard in the field. Leveraging their STRIVETM Capsid Platform and expertise in AAV manufacturing, the company is poised to make significant contributions to the advancement of gene therapy by delivering innovative treatments that address critical medical needs.
Generated from the website